Global burden of gastroesophageal reflux disease, 1990–2021, with projections to 2040: an update from the global burden of disease study 2021
Diseases of the Esophagus · 2025
DOI: 10.1093/dote/doaf113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von Yongqi Dong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology and Laboratory of Gastrointestinal Cancer and Liver Disease, West China Hospital, Sichuan University, N…. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Global Burden of Disease. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Gastroesophageal reflux disease (GERD) imposes substantial global burden. Its recent trends and long-term projections have not been reassessed since the Global Burden of Disease (GBD) 2019 cycle. Using GBD 2021 data, incident and prevalent cases, years lived with disability, and age-standardized rates (ASRs) were estimated for 204 countries from 1990 to 2021. Decomposition analysis categorized changes into population aging, population growth, and epidemiological change. Projections to 2040 used a Bayesian age–period–cohort model, with Nordpred and ARIMA used to assess robustness. From 1990 to 2021, incident cases increased from 180.0 million to 324.1 million (+80.1%), and prevalent cases increased from 450.8 million to 825.6 million (+83.2%). The global age-standardized incidence rate (ASIR) reached 3882 per 100,000 with a peak at ages 30–39 years. ASRs varied by Socio-demographic Index (SDI) levels and exhibited a non-linear negative association overall: decreases at SDI <0.4 and > 0.6, with modest increases at 0.4–0.6. Decomposition analysis indicated population growth contributed most to the incidence increase (+95%), with smaller contributions from aging (+3%) and epidemiological change (+2%). Projections suggest that ASIR will increase to approximately 3939 per 100,000 and ASPR to approximately 9990 per 100,000, whereas ASYR is projected to increase only slightly. Projections were consistent across models. The global burden of GERD continues to rise, primarily associated with demographic expansion and modifiable lifestyle factors. In the absence of enhanced prevention, equitable diagnostic access, and obesity control, incidence and prevalence are anticipated to increase further through 2040. These findings provide region-specific evidence to inform resource allocation and targeted interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology and Laboratory of Gastrointestinal Cancer and Liver Disease, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, China.
- The Second Ward of Internal Medicine, The Public Health Clinical Center of Chengdu, 377 Jingming Road, Jinjiang District, Chengdu, Sichuan 610061, People's Republic of China.
- Department of Gastroenterology, Wushan County People's Hospital of Chongqing, No.168, Guangdongxi Road, Wushan County, Chongqing 404700, People's Republic of China.
ORCID-Profile: Xuecai Zeng
Zitieren
APA
Dong, Y., Xu, S., Zhao, G., & Zeng, X. (2025). Global burden of gastroesophageal reflux disease, 1990–2021, with projections to 2040: an update from the global burden of disease study 2021. Diseases of the Esophagus. https://doi.org/10.1093/dote/doaf113
Vancouver
Dong Y, Xu S, Zhao G, Zeng X. Global burden of gastroesophageal reflux disease, 1990–2021, with projections to 2040: an update from the global burden of disease study 2021. Diseases of the Esophagus. 2025. doi:10.1093/dote/doaf113
BibTeX
@article{Dong2025,
author = {Dong, Yongqi and Xu, Shengsheng and Zhao, Gang and Zeng, Xuecai},
title = {Global burden of gastroesophageal reflux disease, 1990–2021, with projections to 2040: an update from the global burden of disease study 2021},
journal = {Diseases of the Esophagus},
year = {2025},
doi = {10.1093/dote/doaf113}
}
EUVIMED